Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Diabetic Retinopathy Equipment Supplied In Europe
5 equipment items found
Manufactured by:OM Pharma Ltd. based inMeyrin, SWITZERLAND
Doxium (calcium dobesilate) is used for the oral treatment of microangiopathies (e.g. diabetic retinopathy), signs of chronic venous insufficiency in the lower limbs (pain, cramps, paraesthesia, oedema, stasis dermatosis) and haemorrhoidal ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 diabetes, the ...
by:Revenio Group Oyj based inVantaa, FINLAND
iCare DRSplus establishes completely new standards for imaging. For instance, the device produces high-quality images through pupils significantly smaller (2–2.5 mm) than other existing, non-mydriatic fundus cameras. Another unique feature of the iCare DRSplus fundus imaging device, clearly distinguishing it from competitors, is its confocal technology. This allows ...
Manufactured by:3B Scientific GmbH based inHamburg, GERMANY
This human eye model by 3B Scientific® shows an eye enlarged by a factor of 5. It is a perfect tool to assists the healthcare professional in educating patients in the anatomy and changes of the human ...
by:veriNOS pharmaceuticals GmbH based in, NETHERLANDS
Ronopterin is an allosteric inhibitor of inducible NO synthase (iNOS) that rapidly decreases the excessive production of NO resulting from acute overactivation of this enzyme. Ronopterin has no significant effect on the physiological production of NO by other constitutive NO-synthesizing enzymes that are essential for brain and body ...